EMIS Group (EMIS)

Business description

EMIS is a clinical software supplier to the primary care market in the UK (supplying over 50% of UK GP practices), a software supplier to UK pharmacies, and through several acquisitions also supplies specialist and acute care software.

Stock data

Market cap.£593.9m
Last close938.00p
High / Low (52 weeks)1062.0p / 807.0p
Stock market listingLN
Forecast net cash (£m)9.3
Forecast gearing ratio (%)N/A
TeamTechnology
SectorTechnology

Price performance

%1m3m12m
Actual9.87.8(3)
Relative *9.75.7(15.4)

* % Relative to local index

Other companies in sector Show

1Spatial 7digital
Acal accesso Technology Group
ADVA Optical Networking Advanced Computer Software Group
Advanced Micro Devices AIXTRON
All for One Steeb AG Allocate Software
Allot Communications Alpha and Omega Semiconductor
Alphapoint Technology Inc Amazon
Amino Technologies ANADIGICS
Arria NLG Artec technologies
AsiaCell AT&S Austria Technologie & Systemtechnik
Beta Systems Software Blancco Technology Group
blinkx blur Group
Brady Bulletproof Group
Carclo Catapult Group International
CENIT Cerillion provides billing, charging and customer management software, primarily to telecommunicatio
CityFibre Infrastructure Holdings Cliq Digital
CML Microsystems CoAssets
Comptel Craneware
CREALOGIX Cypress Semiconductor
Datagroup DDD Group
Dillistone Group dotDigital
DSP Group e2v technologies
Eagle Eye Eckoh
Edel Elmos Semiconductor
EMIS Emulex
Endace EnWave Corporation
eServGlobal Esker
Evolving Systems EVR Holdings PLC
Expert System Facebook
Featurespace FFastFill
FinLab AG Fintech Group
First Derivatives First Sensor
Focus Solutions Group Foresight Autonomous Holdings
Freelancer Fusionex International
Gamma Communications GB Group
GBST Holdings GeoOp
GFT Globo
GO internet Himax Technologies
Hrvatski Telekom ifa systems
ikeGPS Group Infinera
Inmarsat Innovation Group
InVision IQE
IS Solutions ISRA VISION
IXYS Jenoptik
K3 Business Technology Kainos
Kalibrate Technology Keywords Studios
Learning Technologies Group LRAD Corporation
Magix Manpower Software
Manx Telecom Manz
Maxima Holdings Medicsight
Mensch und Maschine Mercia Technologies
Micro Focus International Micron Technology
Migme Mobile ecosystems
Monitise Montage Technology
Morse mVISE
My Net Fone Nano Dimension
Nanoco Group nearmap
Nemetschek Netcall
NetDimensions Netflix
Nexus Management O2Micro International
OMG OmniVision Technologies
Orion Health Group Outsourcery
Panorama Synergy Pantaleon Entertainment
Patsystems Paysafe Group
Pebble Beach Systems Group Pericom Semiconductor
Phitek Piteco
PLX Technology Pointer Telocation
Pricer Prodware
PSI Pure Wafer
QSC Real Estate Investar Group
REALTECH Redflex Holdings
Redstone Reed Elsevier
Reply SpA Results.com
Rex Bionics Rheinmetall
RM S&T
SCISYS Secunet
Seeing Machines Sepura
Serko Seven Principles
Siemens Sigma Designs
Silicom Silicon Image
SimiGon SinnerSchrader
SITO Mobile SLI Systems
Smartpay Holdings SNP Schneider-Neureither & Partner
Software AG Solera
Spansion Spirent Communications
SQS Software Quality Systems AG Stadium Group
StatPro Group Store Electronic Systems
Straker Translations SuperCom
Synchronica Taptica
Technology sector Texas Instruments
The Marketing Group Thin Film Electronics
Thoughtonomy Tikit Group
Toumaz Track Group
TXT e-solutions TZ Limited
Ubisense Group UMT United Mobility Technology
United Power Technology VASCO Data Security
Vectron Systems Virtual Piggy
Vista Group International Vitec
Vizrt VMob Group
WANdisco Webinar
Wincor Nixdorf WorkPlace Systems International
Xploite Xplore Technologies Corp
YuuZoo

Investment summary

EMIS reported FY16 adjusted profit in line with expectations, despite NHS funding pressures causing difficult trading conditions in certain parts of the business. Cost-cutting programmes in 2016 and a planned reorganisation in 2017 are helping to counteract some of the funding pressure. There is cause for optimism in several areas of the business, where EMIS is growing market share, and a planned expansion of the Patient business could generate material incremental revenues on a five-year view.

Last updated on 04/04/2017

Y/E Dec Revenue (£m) EBITDA (£m) PBT (£m) EPS (p) P/E (x) P/CF (x)
2015A 155.9 52.0 36.6 46.0 20.4 13.8
2016A 158.7 52.3 39.2 49.4 19.0 13.5
2017E 166.2 50.5 37.3 46.0 20.4 13.1
2018E 175.4 54.0 40.2 49.4 19.0 10.8

Last updated on 24/03/2017

Latest research

Latest video

Executive Interview - EMIS Group

Industry outlook

EMIS is the dominant software supplier to the UK GP market, with a greater than 50% market share. It has a strong position in mental and community health, A&E, acute care, specialist care (including diabetic retinopathy screening services) and pharmacies. The roll-out of EMIS Web is in line with the trend to move data to the cloud and will enable EMIS to sell its products to a wider NHS audience. This fits well with the government's strategy to promote greater interoperability between NHS departments.

Last updated on 04/04/2017

Key management

Chris Spencer , CEO
Peter Southby, CFO
Simon Waite, Company Secretary

Company address

Rawdon House
Green Lane, Yeadon
Leeds
LS19 7BY
United Kingdom
0330 024 1269
View website